OLR1 and ischemic stroke: Multiple small cohort studies comparing serum sLOX-1 levels between patients presenting with acute stroke and controls found that serum sLOX-1 levels were significantly raised in ischaemic stroke and haemorrhagic stroke, and that higher sLOX-1 levels independently predicted poorer neurological outcomes [88,89,90].